- Report
- October 2025
- 250 Pages
Global
From €3968EUR$4,490USD£3,496GBP
- Report
- April 2025
- 175 Pages
Global
From €3968EUR$4,490USD£3,496GBP
- Report
- November 2025
- 250 Pages
Global
From €3968EUR$4,490USD£3,496GBP
- Report
- April 2025
- 175 Pages
Global
From €3968EUR$4,490USD£3,496GBP
- Report
- April 2025
- 250 Pages
Global
From €3968EUR$4,490USD£3,496GBP
- Report
- April 2025
- 200 Pages
Global
From €3968EUR$4,490USD£3,496GBP
- Report
- February 2025
- 200 Pages
Global
From €3968EUR$4,490USD£3,496GBP
- Report
- November 2025
- 150 Pages
Global
From €2651EUR$3,000USD£2,336GBP
€3314EUR$3,750USD£2,919GBP
- Report
- September 2025
- 189 Pages
Global
From €3977EUR$4,500USD£3,503GBP
- Report
- June 2025
- 400 Pages
Global
From €4373EUR$4,949USD£3,853GBP
- Report
- June 2025
- 400 Pages
Global
From €4373EUR$4,949USD£3,853GBP
- Report
- October 2025
- 160 Pages
Global
From €2967EUR$3,358USD£2,614GBP
€3491EUR$3,950USD£3,075GBP
- Report
- August 2025
- 150 Pages
Global
From €2967EUR$3,358USD£2,614GBP
€3491EUR$3,950USD£3,075GBP
- Report
- November 2025
- 150 Pages
Global
From €3402EUR$3,850USD£2,997GBP
- Report
- February 2025
- 150 Pages
Global
From €3402EUR$3,850USD£2,997GBP
€4286EUR$4,850USD£3,776GBP
- Report
- April 2025
- 235 Pages
Global
From €3977EUR$4,500USD£3,503GBP
- Report
- July 2025
- 125 Pages
United States
From €3491EUR$3,950USD£3,075GBP
- Report
- July 2025
- 200 Pages
United States
From €2200EUR$2,490USD£1,939GBP
- Report
- November 2025
- 111 Pages
Europe
From €2441EUR$2,763USD£2,151GBP
€2872EUR$3,250USD£2,530GBP
- Report
- November 2025
- 101 Pages
Asia Pacific
From €2441EUR$2,763USD£2,151GBP
€2872EUR$3,250USD£2,530GBP

The Automated Insulin Delivery (AID) market is a subset of the larger diabetes devices market. AID systems are designed to help people with diabetes manage their condition by automatically delivering insulin to the body. These systems are typically composed of an insulin pump, a continuous glucose monitor (CGM), and a control algorithm. The CGM measures glucose levels in the body and sends the data to the control algorithm, which then calculates the amount of insulin needed and sends a signal to the insulin pump to deliver the appropriate dose.
AID systems are designed to provide more accurate and consistent insulin delivery than traditional methods, and can help reduce the risk of hypoglycemia and other diabetes-related complications. They are also designed to be user-friendly and provide users with more control over their diabetes management.
Some companies in the AID market include Medtronic, Insulet, Tandem Diabetes Care, Bigfoot Biomedical, and Senseonics. Show Less Read more